Pomerantz Law Firm Investigates Claims Against Alignment Healthcare
Pomerantz LLP is investigating claims concerning Alignment Healthcare, Inc. (ALHC). The probe focuses on potential securities fraud and other unlawful business practices.
Law firm Pomerantz LLP is investigating claims against Alignment Healthcare, Inc. (NASDAQ: ALHC) and its officers and/or directors. The investigation was initiated following a whistleblower complaint filed by a former Alignment Healthcare executive, which became public on July 8, 2026.
The complaint alleges that Alignment Healthcare engaged in "accounting irregularities" that "artificially inflated" the company's previously reported and projected financial results. Specifically, it claims that "millions of dollars in operating expenses had been systematically misclassified as capital expenditures," impacting Adjusted EBITDA.
Following this news, Alignment Healthcare's stock price fell by $4.02 per share, or 16.7%, closing at $20.03 on July 8, 2026. Pomerantz is now seeking investors who have experienced losses to contact them regarding the probe.
Pomerantz LLP, based in New York, is known for its work in corporate, securities, and antitrust class litigation. The firm has a long history of pursuing cases involving alleged securities fraud and corporate misconduct.